Favorable safety and efficacy of duvelisib maintenance after autologous stem cell transplant in peripheral T-cell lymphomas
Clinical Lymphoma, Myeloma & Leukemia
· Elsevier
Аннотация
Publication date: Available online 12 October 2026 Source: Clinical Lymphoma Myeloma and Leukemia Author(s): Hunter Cochran, Ningying Wu, Raya Saba, Neha Mehta-Shah, Armin Ghobadi, John F. DiPersio, Amanda F. Cashen
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Гематология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Favorable safety and efficacy of duvelisib maintenance after autologous stem cell transplant in peripheral T-cell lymphomas. // Clinical Lymphoma, Myeloma & Leukemia. – URL: https://www.sciencedirect.com/science/article/pii/S2152265026040000?dgcid=rss_sd_all
Favorable safety and efficacy of duvelisib maintenance after autologous stem cell transplant in peripheral T-cell lymphomas. Clinical Lymphoma, Myeloma & Leukemia. https://www.sciencedirect.com/science/article/pii/S2152265026040000?dgcid=rss_sd_all
“Favorable safety and efficacy of duvelisib maintenance after autologous stem cell transplant in peripheral T-cell lymphomas.” Clinical Lymphoma, Myeloma & Leukemia.
@article{article88836,
title = {Favorable safety and efficacy of duvelisib maintenance after autologous stem cell transplant in peripheral T-cell lymphomas},
journal = {Clinical Lymphoma, Myeloma \& Leukemia},
url = {https://www.sciencedirect.com/science/article/pii/S2152265026040000?dgcid=rss_sd_all}
}